Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Oncology

What is Soft Tissue Sarcoma?

At a Glance

Soft tissue sarcoma is a rare cancer that starts in connective tissues like muscle or fat. Because it is highly complex, the most important step after diagnosis is seeking care at a specialized sarcoma center with a multidisciplinary team to ensure the best possible treatment and outcome.

Receiving a diagnosis of soft tissue sarcoma can feel like being dropped into a foreign land without a map. It is natural to feel overwhelmed, anxious, or even frustrated by how little you may have heard about this disease before now. Understanding the basics of what is happening in your body is the first step toward regaining a sense of control.

Three Stabilizing Facts

If you have just been diagnosed, keep these three truths in mind:

  1. You are not alone in your care: Current international guidelines state that because your condition is rare, you must be managed by a multidisciplinary team (a group of different specialists working together) at a dedicated sarcoma center [1][2].
  2. Limb-sparing is the standard: For many years, the primary goal for sarcomas in the arms or legs was amputation. Today, limb-sparing surgery (combined with radiation) is the standard of care, offering survival and function that are often comparable or superior to older methods [3][4].
  3. Specialization improves outcomes: Being treated at a high-volume center by specialists is scientifically linked to higher diagnostic accuracy and better survival rates [5][6].

What is Soft Tissue Sarcoma?

Soft tissue sarcoma (STS) is a family of rare cancers that begin in the body’s connective tissues. While most people are familiar with carcinomas (cancers that start in the “lining” cells of organs like the lungs or breast), sarcomas are different [7]. They arise from mesenchymal cells, which are the building blocks of your body’s support structures, including muscle, fat, blood vessels, nerves, tendons, and deep skin tissues [8].

A Rare and Diverse Family

STS is not just one disease. It is a diverse collection of over 100 different subtypes, each with its own biological “personality” [9]. Because it is so rare, many general practitioners may only see one or two cases in their entire career [10].

  • Who it affects: While it can occur at any age, the likelihood of diagnosis increases as we get older, with a peak incidence in adults over age 65 [10][11].
  • Where it grows: These tumors can appear almost anywhere in the body, though they are most commonly found in the legs, arms, and trunk.

The “Benign Cyst” Red Flag

One of the most dangerous misconceptions about soft tissue sarcoma is that it is just a harmless lump, like a benign cyst or a fatty lipoma (a non-cancerous growth). General surgeons sometimes mistakenly remove these lumps without performing a proper biopsy first. If you have a painless lump that is growing, deep beneath the skin, or larger than a golf ball (about 5 cm), it must be evaluated by a specialist before any surgery takes place [12].

Biologically, sarcomas behave completely differently than common cancers:

Feature Carcinoma (Common) Soft Tissue Sarcoma (Rare)
Origin Epithelial cells (skin/organ linings) [8] Mesenchymal cells (muscle/fat/nerve) [8]
Spread Often travels through the lymph nodes [13] Most often travels through the blood [13]
Common Site of Spread Varies by organ [13] Most frequently the lungs [14]

Genetics and Heredity

Most soft tissue sarcomas happen by chance (sporadic) and are not passed down through families. However, a small percentage are linked to rare genetic conditions, such as Li-Fraumeni syndrome or Neurofibromatosis type 1 (NF1) [7]. If you are diagnosed at a younger age, or if your family has a strong history of various cancers, your doctor may refer you to a genetic counselor to see if inherited mutations played a role in your diagnosis.

Common questions in this guide

What is the difference between a sarcoma and a carcinoma?
Carcinomas start in the epithelial cells that line organs and skin, while sarcomas begin in mesenchymal cells, which form connective tissues like muscle, fat, and nerves. Sarcomas also tend to spread through the bloodstream, primarily to the lungs, rather than through the lymph nodes.
Should I have a doctor remove a suspicious lump immediately?
No. If you have a growing, painless lump deep beneath the skin or larger than a golf ball, it should be evaluated and biopsied by a specialist first. Having a general surgeon remove it before a proper diagnosis can complicate your future treatment.
Is soft tissue sarcoma hereditary?
Most soft tissue sarcomas occur by chance and are not passed down through families. However, a small percentage are linked to rare genetic conditions, such as Li-Fraumeni syndrome or Neurofibromatosis type 1 (NF1).
Will I need an amputation for a sarcoma in my arm or leg?
For many years, amputation was common, but today limb-sparing surgery is the standard of care. When combined with radiation, limb-sparing surgery offers survival rates and functional outcomes that are often comparable or superior to amputation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific histological subtype of my sarcoma, and how does this affect my treatment plan?
  2. 2.How many cases of this specific subtype does this center treat each year?
  3. 3.Has my case been reviewed by a Multidisciplinary Tumor Board (MDT)?
  4. 4.Is a limb-sparing surgery a possibility for me, and what would the functional outcome look like?
  5. 5.Should I or my family undergo genetic counseling to check for hereditary conditions?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS).

    Mata Fernández C, Sebio A, Orcajo Rincón J, et al.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2025; (27(3)):824-836 doi:10.1007/s12094-024-03602-5.

    PMID: 39158802
  2. 2

    Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma.

    Gerrand C, Bate J, Seddon B, et al.

    Clinical sarcoma research 2020; (10(1)):21 doi:10.1186/s13569-020-00144-6.

    PMID: 33292535
  3. 3

    [Resection of soft tissue sarcomas on the thigh].

    Niethard M, Mahr D, Geis S

    Operative Orthopadie und Traumatologie 2026; (38(1)):11-22 doi:10.1007/s00064-025-00924-7.

    PMID: 41379159
  4. 4

    Amputation surgery associated with shortened survival in patients with localized soft tissue sarcoma.

    Matsuoka M, Onodera T, Yokota I, et al.

    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2024; (29(2)):637-645 doi:10.1016/j.jos.2023.02.024.

    PMID: 36931976
  5. 5

    Clinical and surgical effectiveness of the multi-disciplinary standardized management model in the treatment of retroperitoneal liposarcoma: Evidence-based clinical practice experience from Fudan Zhongshan.

    Fan P, Tao P, Wang J, et al.

    Surgery 2024; (175(5)):1368-1376 doi:10.1016/j.surg.2024.01.012.

    PMID: 38395638
  6. 6

    Distinguishing bone and soft tissue infections mimicking sarcomas requires multimodal multidisciplinary team assessment.

    Lex JR, Gregory J, Allen C, et al.

    Annals of the Royal College of Surgeons of England 2019; (101(6)):405-410 doi:10.1308/rcsann.2019.0040.

    PMID: 31155889
  7. 7

    Sarcomas: New Biomarkers and Therapeutic Strategies.

    Nakamura T

    Cancers 2021; (13(20)) doi:10.3390/cancers13205213.

    PMID: 34680364
  8. 8

    Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.

    Mariño-Enríquez A, Bovée JV

    Surgical pathology clinics 2016; (9(3)):457-73.

    PMID: 27523972
  9. 9

    Local recurrence management of extremity soft tissue sarcoma.

    Serban B, Cretu B, Cursaru A, et al.

    EFORT open reviews 2023; (8(8)):606-614 doi:10.1530/EOR-23-0095.

    PMID: 37526250
  10. 10

    Soft Tissue Sarcoma of Extremities: Descriptive Epidemiological Analysis According to National Population-based Study.

    Ebrahimpour A, Chehrassan M, Sadighi M, et al.

    The archives of bone and joint surgery 2022; (10(1)):67-77 doi:10.22038/ABJS.2021.53750.2676.

    PMID: 35291240
  11. 11

    Global burden of soft tissue sarcomas in 204 countries and territories from 1990 to 2021: data from the global burden of disease study 2021.

    Zhou J, Xu S, Long Y, et al.

    BMC public health 2025; (25(1)):1519 doi:10.1186/s12889-025-22782-5.

    PMID: 40275213
  12. 12

    Is Unplanned Excision of Soft Tissue Sarcomas Associated with Worse Oncological Outcomes?-A Systematic Review and Meta-Analysis.

    Larios F, Gonzalez MR, Ruiz-Arellanos K, et al.

    Cancers 2024; (16(2)) doi:10.3390/cancers16020443.

    PMID: 38275885
  13. 13

    Delayed Initiation of Treatment Is Associated With Metastasis of Soft-tissue Sarcoma.

    Araki Y, Yamamoto N, Hayashi K, et al.

    Anticancer research 2020; (40(12)):7009-7015 doi:10.21873/anticanres.14726.

    PMID: 33288596
  14. 14

    Synovial sarcoma presenting as a lung mass and diagnosed by cytology.

    Pyden AD, Lin X

    Diagnostic cytopathology 2016; (44(5)):434-7 doi:10.1002/dc.23446.

    PMID: 26875702

This page provides a general overview of soft tissue sarcoma for educational purposes only. Always consult a multidisciplinary oncology team at a specialized center for personalized medical advice.

Get notified when new evidence is published on Soft tissue sarcoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.